1. Home
  2. VRTS vs BBNX Comparison

VRTS vs BBNX Comparison

Compare VRTS & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Investment Partners Inc.

VRTS

Virtus Investment Partners Inc.

N/A

Current Price

$131.81

Market Cap

864.8M

Sector

Finance

ML Signal

N/A

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

N/A

Current Price

$17.62

Market Cap

997.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRTS
BBNX
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
864.8M
997.9M
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
VRTS
BBNX
Price
$131.81
$17.62
Analyst Decision
Sell
Buy
Analyst Count
4
14
Target Price
★ $145.50
$23.80
AVG Volume (30 Days)
95.5K
★ 1.4M
Earning Date
10-23-2026
10-27-2026
Dividend Yield
★ 7.45%
N/A
EPS Growth
18.24
★ 78.95
EPS
★ 7.72
N/A
Revenue
N/A
★ $100,251,000.00
Revenue This Year
N/A
$25.74
Revenue Next Year
N/A
$44.51
P/E Ratio
$17.05
★ N/A
Revenue Growth
N/A
★ 53.94
52 Week Low
$121.61
$8.80
52 Week High
$195.00
$32.71

Technical Indicators

Market Signals
Indicator
VRTS
BBNX
Relative Strength Index (RSI) 35.22 37.29
Support Level $124.58 $15.76
Resistance Level $149.55 $18.20
Average True Range (ATR) 3.79 1.08
MACD 1.17 -0.46
Stochastic Oscillator 45.70 4.62

Price Performance

Historical Comparison
VRTS
BBNX

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: